News
By Dr. Rodney Ouellette, M.D., Ph.D.
New Brunswick faces daunting challenges in the delivery of health care services to residents. The current public debate between Saint John and Moncton regarding investment in a duplicate gene sequencing facility is another example of the consequences when we overlook opportunities to collaborate and optimize.
Patients want and need access to the best available diagnostic technologies. In the area of gene sequencing we already have the capability right here in New Brunswick through Vitalité Health Network and Atlantic Canada Research Institute (ACRI). The Molecular Genetics Laboratory is located in and part of the Dr GL Dumont University Hospital laboratories which was accredited in September 2014 by the Institute for Quality Management in Healthcare (formerly Ontario Laboratories Association). Any clinician in New Brunswick can access this testing through the Vitalité Health Network. Our professionals are skilled and available for consultation. Our service is timely and costs are comparable or lower to those charged by other labs operating outside of the province. As good stewards of health care dollars we believe should be using this existing facility taking advantage of our capacity before investing in another lab when there are so many pressing priorities to improving health care in our province.
New Brunswick faces daunting challenges in the delivery of health care services to residents. The current public debate between Saint John and Moncton regarding investment in a duplicate gene sequencing facility is another example of the consequences when we overlook opportunities to collaborate and optimize.
Patients want and need access to the best available diagnostic technologies. In the area of gene sequencing we already have the capability right here in New Brunswick through Vitalité Health Network and Atlantic Canada Research Institute (ACRI). The Molecular Genetics Laboratory is located in and part of the Dr GL Dumont University Hospital laboratories which was accredited in September 2014 by the Institute for Quality Management in Healthcare (formerly Ontario Laboratories Association). Any clinician in New Brunswick can access this testing through the Vitalité Health Network. Our professionals are skilled and available for consultation. Our service is timely and costs are comparable or lower to those charged by other labs operating outside of the province. As good stewards of health care dollars we believe should be using this existing facility taking advantage of our capacity before investing in another lab when there are so many pressing priorities to improving health care in our province.
The Atlantic Cancer Research Institute is very happy to welcome Dr. Jocelyn Paré, recipient of the New Brunswick Innovation Research Chair in Medical Technologies.
Justin Bujold, Roxann Guerrette, Rémi Richard et Annie-Pier Beauregard
Acute Lymphoblastic Leukemia (ALL) is rarely found in adults but will affect more than a fourth of children diagnosed with cancer. With around 90% remission, this cancer is still a very morbid disease with high mortality rates.
Personalized medicine is the most promising alternative to fight cancer. Briefly, this new procedure allows for the detection of specific mutations indicative of a specific cancers allowing doctors to access better treatment.
(Moncton, N.B.) – February 4th, 2015 – Taking place under the tagline 'Not beyond us', World Cancer Day takes a positive and proactive approach to the fight against cancer, highlighting that solutions do exist across the continuum of cancers, and that they are within our reach. This year's campaign focuses on four key areas: choosing healthy lives, delivering early detection, achieving treatment for all and maximising quality of life.
(Moncton, NB) – Friday, January 30, 2015 – Imagine if everyone one the planet was "inspired to Relish their life through their dreams, passions and aspirations."
This is exactly what inspires reLiSH Gourmet Burgers to make a difference in people and their journey on Earth. Their mission to reLiSH life is what has inspired reLiSH Gourmet Burgers all across Atlantic Canada to team up with the Atlantic Cancer Research Institute in the fight against cancer with the creation of The Terminator burger. Last year, for its first edition, relish created the Terminator which is made-up of reLiSH's signature burger The Simpleton™ topped off with salsa, avocado, pepper jack cheese and crispy bacon. This burger had a warm welcome and was such a success that people wanted more and kept requesting it after the event was over. It took one year for the return of the Terminator which will be featured at your local reLISH burger restaurant in light of World Cancer Day. A portion of the sales from each Terminator burger sold on February 3rd and 4th will be donated to the Atlantic Cancer Research Institute.
"reLiSH Gourmet burgers and our franchisee operators are really excited about the Terminator program this year," says Rivers Corbett, co-founder of reLiSH Gourmet Burgers. "ACRI is a key community partner and we relish this opportunity to help out. This mouth-watering burger is sure to leave you completely satisfied, not only because it tastes so good, but also because by purchasing one, you know you'll be supporting a great cause – terminating cancer."
"We at ACRI are extremely grateful to be able to partner with community leaders like reLiSH Gourmet Burgers in such initiatives," says Sophie Thériault, Director of Business Development and Communications at ACRI. "More than one out of three people in Atlantic Canada will be affected by this terrible disease and raising money to fight to terminate cancer with innovative and motivated partners helps us make a difference. We are thankful to reLiSH Gourmet Burgers for supporting, for the second year in a row, the Atlantic Cancer Research Institute with this pan-Atlantic initiative and invite you to go and try The Terminator. They really are delicious!"
Those who can't let go of their favorite reLiSH burger will be able to make a donation in the amount of their choice, write their name on an "Atlantic Cancer Research Institute" Logo and the staff at reLiSH gourmet burgers will proudly put it up for everyone to see the supporters who encourage cancer research conducted right here in Atlantic Canada!
Visit any of the four reLish locations in Fredericton, Halifax and St. Johns and help us in the fight to terminate cancer.
About Atlantic Cancer Research Institute
The Atlantic Cancer Research Institute (ACRI) is a private, not for profit research organization created in 1998. Located at the Dr.- George-L. Dumont University Hospital in Moncton, NB, it employs a multidisciplinary research team of over 50 people. Unique to the region and operating a modern biomedical research laboratory, this entrepreneurial team is striving to innovate by accelerating its understanding of cancer, thus paving the way to better diagnosis, more accurate patient stratification and drug discovery.
For more information, please visit www.atlanticcancer.ca or on Facebook, Atlantic Cancer Research. www.cancerresearchsaveslives.ca
-30-
For further information:
riVeRS Corbett
co-founder
reLiSH Gourmet Burgers
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.reLiSHCanada.com
www.riVeRSCorbett.me
This is exactly what inspires reLiSH Gourmet Burgers to make a difference in people and their journey on Earth. Their mission to reLiSH life is what has inspired reLiSH Gourmet Burgers all across Atlantic Canada to team up with the Atlantic Cancer Research Institute in the fight against cancer with the creation of The Terminator burger. Last year, for its first edition, relish created the Terminator which is made-up of reLiSH's signature burger The Simpleton™ topped off with salsa, avocado, pepper jack cheese and crispy bacon. This burger had a warm welcome and was such a success that people wanted more and kept requesting it after the event was over. It took one year for the return of the Terminator which will be featured at your local reLISH burger restaurant in light of World Cancer Day. A portion of the sales from each Terminator burger sold on February 3rd and 4th will be donated to the Atlantic Cancer Research Institute.
"reLiSH Gourmet burgers and our franchisee operators are really excited about the Terminator program this year," says Rivers Corbett, co-founder of reLiSH Gourmet Burgers. "ACRI is a key community partner and we relish this opportunity to help out. This mouth-watering burger is sure to leave you completely satisfied, not only because it tastes so good, but also because by purchasing one, you know you'll be supporting a great cause – terminating cancer."
"We at ACRI are extremely grateful to be able to partner with community leaders like reLiSH Gourmet Burgers in such initiatives," says Sophie Thériault, Director of Business Development and Communications at ACRI. "More than one out of three people in Atlantic Canada will be affected by this terrible disease and raising money to fight to terminate cancer with innovative and motivated partners helps us make a difference. We are thankful to reLiSH Gourmet Burgers for supporting, for the second year in a row, the Atlantic Cancer Research Institute with this pan-Atlantic initiative and invite you to go and try The Terminator. They really are delicious!"
Those who can't let go of their favorite reLiSH burger will be able to make a donation in the amount of their choice, write their name on an "Atlantic Cancer Research Institute" Logo and the staff at reLiSH gourmet burgers will proudly put it up for everyone to see the supporters who encourage cancer research conducted right here in Atlantic Canada!
Visit any of the four reLish locations in Fredericton, Halifax and St. Johns and help us in the fight to terminate cancer.
About Atlantic Cancer Research Institute
The Atlantic Cancer Research Institute (ACRI) is a private, not for profit research organization created in 1998. Located at the Dr.- George-L. Dumont University Hospital in Moncton, NB, it employs a multidisciplinary research team of over 50 people. Unique to the region and operating a modern biomedical research laboratory, this entrepreneurial team is striving to innovate by accelerating its understanding of cancer, thus paving the way to better diagnosis, more accurate patient stratification and drug discovery.
For more information, please visit www.atlanticcancer.ca or on Facebook, Atlantic Cancer Research. www.cancerresearchsaveslives.ca
-30-
For further information:
riVeRS Corbett
co-founder
reLiSH Gourmet Burgers
www.reLiSHCanada.com
www.riVeRSCorbett.me
NEW BRUNSWICK, October 30, 2014 - The Canadian Cancer Society, in partnership with the New Brunswick Health Research Foundation and Craig's Cause Pancreatic Cancer Society, has announced a grant of $197,500 to support New Brunswick cancer research scientists exploring the development of a blood test to detect pancreatic cancer at an early stage.
"The survival rate for pancreatic cancer is only eight percent, so finding a way to detect it earlier could significantly improve outcomes for many patients," said Anne McTiernan-Gamble, CEO of the Canadian Cancer Society New Brunswick. "We're extremely pleased to partner with Craig's Cause Pancreatic Cancer Society and the New Brunswick Health Research Foundation in funding this exciting research, led by Drs. Stephen Lewis, Rodney Ouellette and Anirban Ghosh."
ACRI`s research team publishes article detailing its research on extracellular vesicle isolation.
Rapid Isolation of Extracellular Vesicles from Cell Culture and Biological Fluids Using a Synthetic Peptide with Specific Affinity for Heat Shock Proteins
